Clinical Trial Update: The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of N-acetylcysteine on cortical erosion in early-stage schizophrenia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorder Nos
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Indiana University | Conditions: Schizophrenia, Psychotic Disorder NOS | Phase 4 | Status: COMPLETED | Results posted: 2019-05-08